These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 932502)

  • 1. Comparison of rates of clearance of human fibroblast and leukocyte interferon from the circulatory system of rabbits.
    Edy VG; Billiau A; De Somer P
    J Infect Dis; 1976 Jun; 133 Suppl():A18-21. PubMed ID: 932502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of human leukocyte interferon.
    Cantell K; Pyhälä L
    J Infect Dis; 1976 Jun; 133 Suppl():A6-12. PubMed ID: 932506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic properties of human fibroblast and leukocyte interferon in rabbits.
    Vilcek J; Sulea IT; Zerebeckyj IL; Yip YK
    J Clin Microbiol; 1980 Jan; 11(1):102-5. PubMed ID: 7354125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two antigenically distinct species of human interferon.
    Havell EA; Berman B; Ogburn CA; Berg K; Paucker K; Vilcek J
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):2185-7. PubMed ID: 49055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice.
    Billiau A; Heremans H; Ververken D; van Damme J; Carton H; de Somer P
    Arch Virol; 1981; 68(1):19-25. PubMed ID: 6166278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity chromatography of human leukocyte and diploid cell interferons on sepharose-bound antibodies.
    Berg K; Ogburn CA; Paucker K; Mogensen KE; Cantell K
    J Immunol; 1975 Feb; 114(2 Pt 1):640-4. PubMed ID: 1168221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of human recombinant interferon-beta in monkeys and rabbits.
    Gomi K; Morimoto M; Inoue A; Kobayashi H; Deguchi T; Hara T; Nakamizo N
    Gan; 1984 Mar; 75(3):292-300. PubMed ID: 6724230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance of human interferon in rabbits induced to make rabbit interferon.
    Pyhala L; Cantell K
    Proc Soc Exp Biol Med; 1974 Jun; 146(2):394-7. PubMed ID: 4834448
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of effects of leukocyte and fibroblast interferon on immunological parameters in cancer patients.
    Lucero MA; Magdelenat H; Fridman WH; Pouillart P; Billardon C; Billiau A; Cantell K; Falcoff E
    Eur J Cancer Clin Oncol; 1982 Mar; 18(3):243-51. PubMed ID: 6178592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kinetics of human interferon clearance in gibbons.
    Skreko F; Zajac I; Bahnsen HP; Haff RF; Cantell K
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):946-7. PubMed ID: 4692028
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating interferon in rabbits and monkeys after administration of human gamma interferon by different routes.
    Cantell K; Hirvonen S; Pyhälä L; De Reus A; Schellekens H
    J Gen Virol; 1983 Aug; 64 (Pt 8)():1823-6. PubMed ID: 6409993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon.
    Weimar W; Stitz L; Billiau A; Cantell K; Schellekens H
    J Gen Virol; 1980 May; 48(1):25-30. PubMed ID: 6155433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple active sites on human interferons.
    Paucker K; Dalton BJ; Ogburn CA; Törmä E
    Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4587-91. PubMed ID: 53841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing antibodies against human leukocyte, lymphoblastoid and fibroblast interferons elicited by immunization with human leukocyte interferon.
    Pyhälä
    Acta Pathol Microbiol Scand C; 1978 Dec; 86C(6):291-8. PubMed ID: 726897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating interferon in rabbits after administration of human interferon by different routes.
    Cantell K; Pyhälä L
    J Gen Virol; 1973 Jul; 20(1):97-104. PubMed ID: 4356685
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacokinetics of human interferons].
    Furue H; Kobayashi H; Komuro T; Kako M; Mugitani H; Fuse K; Kaise R; Nagai K; Takahashi T; Hirota F
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):935-42. PubMed ID: 6721508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical application of fibroblast interferon--an overview.
    Billiau A
    Med Oncol Tumor Pharmacother; 1984; 1(2):87-96. PubMed ID: 6400034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kinetics of interferon clearance in mice: comparison of mouse and human interferon.
    Kiuchi Y; Yonehara M; Okada K; Suzuki J; Kobayashi S
    Jikken Dobutsu; 1984 Jan; 33(1):85-9. PubMed ID: 6468509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of rat fibroblast interferon.
    Abreu SL
    J Pharmacol Exp Ther; 1983 Jul; 226(1):197-200. PubMed ID: 6191024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of liver in the catabolism of human alpha- and beta-interferon.
    Bocci V; Pacini A; Bandinelli L; Pessina GP; Muscettola M; Paulesu L
    J Gen Virol; 1982 Jun; 60(Pt 2):397-400. PubMed ID: 6180128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.